nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—CHRM5—skin of body—acquired immunodeficiency syndrome	0.0166	0.0955	CbGeAlD
Metixene—CHRM4—nervous system—acquired immunodeficiency syndrome	0.0131	0.0756	CbGeAlD
Metixene—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.0126	0.0728	CbGeAlD
Metixene—CHRM5—nervous system—acquired immunodeficiency syndrome	0.0103	0.0591	CbGeAlD
Metixene—CHRM4—brain—acquired immunodeficiency syndrome	0.01	0.0578	CbGeAlD
Metixene—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.00988	0.0569	CbGeAlD
Metixene—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00806	0.0464	CbGeAlD
Metixene—CHRM5—brain—acquired immunodeficiency syndrome	0.00784	0.0452	CbGeAlD
Metixene—CHRM3—digestive system—acquired immunodeficiency syndrome	0.00742	0.0427	CbGeAlD
Metixene—CHRM2—nervous system—acquired immunodeficiency syndrome	0.00705	0.0406	CbGeAlD
Metixene—CHRM1—lung—acquired immunodeficiency syndrome	0.00692	0.0399	CbGeAlD
Metixene—HTR2C—nervous system—acquired immunodeficiency syndrome	0.00679	0.0391	CbGeAlD
Metixene—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.00678	0.0391	CbGeAlD
Metixene—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.00654	0.0376	CbGeAlD
Metixene—CHRM1—nervous system—acquired immunodeficiency syndrome	0.00641	0.0369	CbGeAlD
Metixene—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00617	0.0356	CbGeAlD
Metixene—CHRM3—nervous system—acquired immunodeficiency syndrome	0.00574	0.033	CbGeAlD
Metixene—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.00552	0.0318	CbGeAlD
Metixene—CHRM2—brain—acquired immunodeficiency syndrome	0.00538	0.031	CbGeAlD
Metixene—HTR2C—brain—acquired immunodeficiency syndrome	0.00519	0.0299	CbGeAlD
Metixene—CHRM1—brain—acquired immunodeficiency syndrome	0.0049	0.0282	CbGeAlD
Metixene—CHRM3—brain—acquired immunodeficiency syndrome	0.00439	0.0253	CbGeAlD
Metixene—CHRM5—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00284	0.00344	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00284	0.00343	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00282	0.00342	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00279	0.00338	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00278	0.00337	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00277	0.00336	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00276	0.00333	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00272	0.00329	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.0027	0.00327	CbGpPWpGaD
Metixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00267	0.00323	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00262	0.00318	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00262	0.00318	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00262	0.00317	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00262	0.00317	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00262	0.00317	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00259	0.00314	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00259	0.00314	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00255	0.00309	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00251	0.00304	CbGpPWpGaD
Metixene—CHRM2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00248	0.003	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00246	0.00298	CbGpPWpGaD
Metixene—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00243	0.00294	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00235	0.00284	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00234	0.00284	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00232	0.00281	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00231	0.0028	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00231	0.0028	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00231	0.0028	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00226	0.00274	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00226	0.00273	CbGpPWpGaD
Metixene—CHRM2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00223	0.0027	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.0022	0.00267	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00216	0.00261	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00213	0.00257	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00212	0.00256	CbGpPWpGaD
Metixene—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.0021	0.00254	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.0021	0.00254	CbGpPWpGaD
Metixene—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00209	0.00253	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00208	0.00252	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00207	0.00251	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00204	0.00247	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00203	0.00246	CbGpPWpGaD
Metixene—CHRM3—Metabolism—TAT—acquired immunodeficiency syndrome	0.00202	0.00245	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.002	0.00242	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.002	0.00242	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.002	0.00242	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00199	0.00241	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00199	0.00241	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00199	0.00241	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00197	0.00239	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00197	0.00239	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00197	0.00239	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00195	0.00236	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00195	0.00236	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00195	0.00235	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00193	0.00233	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.0019	0.0023	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.0019	0.0023	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00188	0.00227	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.0018	0.00218	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00179	0.00217	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00179	0.00217	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00178	0.00216	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00178	0.00215	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00177	0.00214	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00176	0.00213	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00176	0.00213	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00174	0.00211	CbGpPWpGaD
Metixene—CHRM3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00172	0.00208	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00171	0.00207	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00171	0.00207	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00171	0.00207	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00171	0.00206	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00168	0.00203	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00168	0.00203	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00164	0.00198	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00164	0.00198	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00162	0.00196	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.0016	0.00194	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.0016	0.00194	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00159	0.00192	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00155	0.00188	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00155	0.00187	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00152	0.00184	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00152	0.00184	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00152	0.00184	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00152	0.00183	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.0015	0.00182	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00148	0.00179	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00146	0.00176	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00146	0.00176	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.0014	0.00169	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00139	0.00168	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00137	0.00166	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00137	0.00165	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00135	0.00164	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00134	0.00162	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00134	0.00162	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00131	0.00158	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00131	0.00158	CbGpPWpGaD
Metixene—CHRM2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.0013	0.00158	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00127	0.00154	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00126	0.00153	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00126	0.00152	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00122	0.00148	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00121	0.00146	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00121	0.00146	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.0012	0.00146	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.0012	0.00145	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.0012	0.00145	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.0012	0.00145	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00119	0.00144	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00119	0.00144	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00119	0.00144	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00119	0.00144	CbGpPWpGaD
Metixene—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00117	0.00142	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00116	0.0014	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00115	0.0014	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00115	0.0014	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00115	0.00139	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00115	0.00139	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00115	0.00139	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00114	0.00138	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00114	0.00138	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00114	0.00138	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00113	0.00137	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00113	0.00137	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00113	0.00136	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00113	0.00136	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00112	0.00135	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00112	0.00135	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00111	0.00134	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.0011	0.00133	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00109	0.00132	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00109	0.00132	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00109	0.00132	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00108	0.0013	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00106	0.00128	CbGpPWpGaD
Metixene—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.00105	0.00127	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00104	0.00126	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00104	0.00126	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00104	0.00126	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00103	0.00125	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00103	0.00124	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00103	0.00124	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00102	0.00124	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00102	0.00124	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00101	0.00123	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00101	0.00123	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00101	0.00122	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000998	0.00121	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000995	0.0012	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00098	0.00119	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000956	0.00116	CbGpPWpGaD
Metixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000955	0.00116	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000915	0.00111	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000903	0.00109	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000899	0.00109	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000899	0.00109	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000896	0.00108	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00089	0.00108	CbGpPWpGaD
Metixene—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000871	0.00105	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000861	0.00104	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000861	0.00104	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000859	0.00104	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000857	0.00104	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000848	0.00103	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000846	0.00102	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000844	0.00102	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000836	0.00101	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000825	0.000998	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000825	0.000998	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000822	0.000995	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000814	0.000985	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00078	0.000944	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000778	0.000941	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000774	0.000937	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000772	0.000934	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00077	0.000932	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000769	0.00093	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000766	0.000927	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000764	0.000925	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000759	0.000918	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000746	0.000903	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000713	0.000862	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00071	0.00086	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000703	0.000851	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000703	0.000851	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000702	0.000849	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000702	0.000849	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000701	0.000848	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000694	0.00084	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000684	0.000827	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000673	0.000815	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000663	0.000803	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000655	0.000792	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000645	0.00078	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000644	0.00078	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000642	0.000777	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000636	0.00077	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000635	0.000769	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000616	0.000745	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000606	0.000733	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000606	0.000733	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000604	0.000731	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000604	0.000731	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000602	0.000729	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000598	0.000724	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000598	0.000724	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00059	0.000714	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000577	0.000698	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000534	0.000646	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000526	0.000636	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000518	0.000627	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000481	0.000582	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00047	0.000569	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000461	0.000558	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00046	0.000556	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000455	0.000551	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000454	0.000549	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000453	0.000548	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000448	0.000542	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000447	0.000541	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000446	0.00054	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000442	0.000534	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000415	0.000503	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000414	0.000501	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00041	0.000496	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000406	0.000492	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000405	0.00049	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000401	0.000485	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000356	0.000431	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000354	0.000429	CbGpPWpGaD
Metixene—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	0.000353	0.000427	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000341	0.000412	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000339	0.00041	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000278	0.000336	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000276	0.000335	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.00024	0.00029	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000239	0.000289	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000239	0.000289	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000238	0.000288	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000237	0.000287	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000236	0.000285	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000209	0.000253	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.0002	0.000242	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000163	0.000198	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000141	0.000171	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000141	0.00017	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000139	0.000168	CbGpPWpGaD
